Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07507513 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Name: The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC — clinical trial record (NCT07507513)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2026-03-28

View on ClinicalTrials.gov ↗

Amendment history

2026-07-26

Study Status, Contacts/Locations v1

Recruitment opened

Start dateestimated 2026-03-31→confirmed 2026-03-28

Study sitesdetails revised at 1 of 1 site

2026-03-26

Original filing

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

Ulcerative Colitis

582 trials monitored

See 29 trials at risk

This study will evaluate the efficacy and safety of 627 in patients with UC.

Trial Details

NCT Number	NCT07507513
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Ulcerative Colitis (UC)
Enrollment	288 participants
Start Date	2026-03-28
Primary Completion	2029-02-28 (estimated)
Study Completion	2029-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-28